Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Study for Confirmation of Efficacy and Safety of Acoustic CR®-Neuromodulation by CE Marked ANM T30 CR®-System in a "Real Life" Patient Population With Chronic Tonal Tinnitus

NCT01435317 is registered in ClinicalTrials.gov with ANM Adaptive Neuromodulation GmbH as lead sponsor.

NCT NCT01435317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01435317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Study for Confirmation of Efficacy and Safety of Acoustic CR®-Neuromodulation by CE Marked ANM T30 CR®-System in a "Real Life" Patient Population With Chronic Tonal Tinnitus
Lead sponsor
ANM Adaptive Neuromodulation GmbH
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2011
Completion date
July 31, 2014
Enrollment
200 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus